MDMA, Trauma, Addictions and Psychedelics

January 26, 2024 Lynne Nardizzi

Dr. Ben Sessa discusses his latest research here.

MDMA History

July 25, 2023 Lynne Nardizzi

The wild history of MDMA: 5 Questions for author Rachel Nuwer.

MDMA Therapy, Things to Know

May 26, 2023 Lynne Nardizzi

Here’s an unofficial primer on risks, protocols, and some other stuff for MDMA therapy.

Update: MDMA-Assisted Therapy for Treatment of PTSD

April 9, 2023 Lynne Nardizzi

MAPS PBC announces positive topline results from long-term observational follow-up study on MDMA-assisted therapy for treatment of PTSD.

Interim results show improvements in PTSD symptom severity lasted at least six months after the last treatment session.

Findings are consistent with previously published Phase 2 data[1] on the sustained effect of MDMA-assisted therapy for the treatment of PTSD.

Guide to MDMA

April 7, 2023 Lynne Nardizzi

Here is the MDMA-assisted therapy guide from Psychedelic Support.

When combined with therapy, MDMA is proving helpful for PTSD and other mental health conditions.

Learn more about the effects, dosage, therapeutic approach, and clinical trial findings.

MDMA-Assisted Therapy and PTSD

January 13, 2023 Lynne Nardizzi

Here’s the official statement from MAPS!

The results confirmed findings from MAPP1; no serious adverse events were observed among the participants
In a first for psychedelic-assisted therapy trials, more than half of MAPP2 participants identify as people of color

MDMA and Eating Disorders

November 16, 2022 Lynne Nardizzi

MDMA-assisted psychotherapy shows promise in the treatment of eating disorder symptoms.

MDMA and Chronic Pain

November 7, 2022 Lynne Nardizzi

New research shows that MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder.

MDMA and Trauma

October 27, 2022 Lynne Nardizzi

Reports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.

New Psychedelic Research- Interview with a Psychiatrist

August 1, 2022 Lynne Nardizzi

Check out this great interview with the latest research on MDMA, psilocybin, and the interaction of psychiatric medications.

Making MDMA Legal

October 14, 2021 Lynne Nardizzi

Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a fully owned subsidiary of the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS).

Working for almost two decades to make MDMA a legal, FDA-approved medicine, Amy began as a pro bono consultant for MAPS in 2003, helping to create MAPS’ clinical department and managing the MDMA Clinical Development Program.

Her painstaking time and efforts have played a key role in seeing MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) through clinical trials, driving it ever-closer to being a legal, accessible therapeutic treatment in the US and abroad.

Blog